Search filters

List of works by Bruce D. Cheson

"Coach” for a team of junior hematologists specializing in lymphoma

scientific article published on March 1, 2013

(18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma.

scientific article published on 20 April 2016

2'-Deoxycoformycin (pentostatin) for lymphoid malignancies. Rational development of an active new drug

scientific article published on May 1988

2'-Deoxycoformycin after failure of alpha-interferon in hairy cell leukemia

scientific article published on 01 October 1989

2'-Deoxycoformycin therapy in adult T-cell leukemia/lymphoma

scientific article

A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype.

scientific article

A comparative analysis of prognostic factor models for follicular lymphoma based on a phase III trial of CHOP-rituximab versus CHOP + 131iodine--tositumomab.

scientific article published on 15 October 2013

A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes

scientific article

A multicenter phase II trial of 4'-iodo-4'deoxydoxorubicin (IDOX) in primary amyloidosis (AL).

scientific article

A perspective on dose-intensive therapy with autologous bone marrow transplantation for solid tumors

scientific article published on March 1991

A phase 1 study of lenalidomide and ibrutinib in combination with rituximab in relapsed and refractory CLL

scientific article published on 01 April 2018

A phase 2 trial of extended induction epratuzumab and rituximab for previously untreated follicular lymphoma: CALGB 50701.

scientific article published on 06 August 2013

A phase I study of PRO131921, a novel anti-CD20 monoclonal antibody in patients with relapsed/refractory CD20+ indolent NHL: correlation between clinical responses and AUC pharmacokinetics

scientific article

A phase I study of bendamustine, lenalidomide and rituximab in relapsed and refractory lymphomas

scientific article published on 7 March 2015

A phase I study of the pan bcl-2 family inhibitor obatoclax mesylate in patients with advanced hematologic malignancies

scientific article published in December 2008

A phase I/II study of galiximab (an anti-CD80 monoclonal antibody) in combination with rituximab for relapsed or refractory, follicular lymphoma

scientific article published on 29 April 2007

A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors

scientific article

A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma.

scientific article published on 17 October 2011

A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin's lymphoma (NHL): CALGB 50803 (Alliance).

scientific article

A phase III study of anti-B4-blocked ricin as adjuvant therapy post-autologous bone marrow transplant: CALGB 9254.

scientific article published on 28 January 2011

A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL

article

A summer of change in hematologic malignancies: highlights in B-Cell malignancies from the 2013 ASCO, EHA, and ICML meetings.

scientific article

A summer of hematologic science. Highlights from the 45th Annual Meeting of the American Society of Clinical Oncology, the 14th Congress of the European Hematology Association, and the 2009 Pan Pacific Lymphoma Conference.

scientific article published in September 2009

Acalabrutinib monotherapy in patients with Waldenström macroglobulinemia: a single-arm, multicentre, phase 2 study

scientific article published on 19 December 2019

Accessible intrachain disulfide bonds in hybrids of light chains

scientific article

Accurate reporting of adverse events in chronic lymphocytic leukemia and non-Hodgkin lymphoma

scientific article published on July 2011

Adult Burkitt lymphoma: too soon to declare victory.

scientific article published in November 2008

Although many of the items are natural products, we do not know what harm they might cause in the often excessive quantities that are recommended

scientific article published on 01 July 2007

American Society of Hematology (ASH) meeting

scientific article published in January 2014

An oncoethical issue

scientific article published on 01 April 2006

Another summer of hematology

scientific article published on 01 August 2010

Anti-CD22 and anti-CD79B antibody drug conjugates are active in different molecular diffuse large B-cell lymphoma subtypes.

scientific article published on 24 February 2015

Anti-CD79B Antibody–Drug Conjugate DCDS0780A in Patients with B-Cell Non-Hodgkin Lymphoma: Phase 1 Dose-Escalation Study

Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK inhibition as an Effective Strategy

scientific article published on 20 March 2020

Assisted suicide for patients with terminal illness

scientific article

Asymptomatic diffuse "encephalitic" cerebral toxoplasmosis in a patient with chronic lymphocytic leukemia: case report and review of the literature

scientific article published on 15 March 2009

Atheists don’t have no songs.

scientific article published in June 2013

Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factors.

scientific article published in November 1990

Autologous bone marrow transplantation. Current status and future directions

scientific article published on January 1989

Autotransplants in multiple myeloma: what have we learned?

scientific article published in August 1996

Availability and appropriateness of allogeneic bone marrow transplantation for chronic myeloid leukemia in 10 countries

scientific article

BEACOPP or no BEACOPP?

scientific article published in November 2013

Basophilic stippling of red blood cells: A nonspecific finding of multiple etiology ⬇️

scientific article published on January 1, 1984

Bendamustine Produces Durable Responses With an Acceptable Safety Profile in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma ⬇️

scientific article published on 01 December 2010

Bendamustine in CLL: How quickly will today's consensus become tomorrow's memory?

scientific article published on 11 August 2014

Bendamustine in chronic lymphocytic leukemia and non-Hodgkin’s lymphoma ⬇️

scientific article published on September 1, 2010

Bendamustine in patients with rituximab-refractory indolent and transformed non-Hodgkin's lymphoma: results from a phase II multicenter, single-agent study

scientific article

Bendamustine in the treatment of hematologic malignancies. Introduction

scientific article published on 01 August 2002

Bendamustine induced neurotoxicity

scientific article published in November 2009

Bendamustine is effective therapy in patients with rituximab-refractory, indolent B-cell non-Hodgkin lymphoma: results from a Multicenter Study

scientific article

Bendamustine: a new therapeutic option for hematologic malignancies

scientific article published on 01 September 2008

Bendamustine: mechanism of action and clinical data

scientific article published on August 1, 2011

Bendamustine: rebirth of an old drug

scientific article

Bendamustine: role and evidence in lymphoma therapy, an overview

scientific article published on 04 February 2014

Bexxar (Corixa/GlaxoSmithKline).

scientific article

Biologic therapies for low-grade lymphomas

scientific article

Biomarkers for Risk Stratification in Patients With Previously Untreated Follicular Lymphoma Receiving Anti-CD20-based Biological Therapy

scientific article published on 30 October 2020

Bone marrow biopsy for the initial staging of patients with lymphoma: it's time to eliminate this procedure in selected patients

scientific article published in December 2013

Bone marrow transplantation: current perspectives and future directions

scientific article published on June 1986

Bortezomib consolidation or maintenance following immunochemotherapy and autologous stem cell transplantation for mantle cell lymphoma: CALGB/Alliance 50403 ⬇️

scientific article published on 13 March 2020

Bortezomib, Bendamustine, and Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma: The Phase II VERTICAL Study ⬇️

scientific article published on September 1, 2011

Bortezomib: a proteasome inhibitor with an evolving role in select subtypes of B-cell non-Hodgkin's lymphoma

scientific article published on April 2012

Brentuximab vedotin plus nivolumab as first-line therapy in older or chemotherapy-ineligible patients with Hodgkin lymphoma (ACCRU): a multicentre, single-arm, phase 2 trial

scientific article published on 01 October 2020

Building quality of life assessment into cancer treatment studies

scientific article published on 01 June 1992

Burnout

CALGB 150905 (Alliance): rituximab broadens the antilymphoma response by activating unlicensed NK cells

scientific article

CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET

scientific article published on 26 July 2018

CHOP plus rituximab--balancing facts and opinion

scientific article published in January 2002

CLL and NHL: the end of chemotherapy?

scientific article

CLL response criteria

scientific article published on 01 May 2006

CML: new biologic therapies, endpoints and questions

scientific article published on 01 September 1987

CT/PET scan

scientific article published on 01 September 2005

Cancer chemoprevention trials.

scientific article published in March 1996

Cancer clinical trials. Clinical trials programs

scientific article published in November 1991

Cephalotaxine esters: antileukemic advance or therapeutic failure?

scientific article published on September 1988

Chemotherapy and bone marrow transplantation for myelodysplastic syndromes

scientific article published on February 1, 1992

Chemotherapy is superior to sequential hemibody irradiation for remission consolidation in multiple myeloma: a Southwest Oncology Group study

scientific article published in September 1990

Chronic lymphocytic leukemia

scientific article published on 01 January 1999

Chronic lymphocytic leukemia and hairy-cell leukemia

scientific article published on February 1991

Chronic lymphocytic leukemia and hairy-cell leukemia.

scientific article published on July 1994

Chronic lymphocytic leukemia: recommendations

scientific article published in April 1989

Chronic lymphocytic leukemia: staging and prognostic factors

scientific article published on February 1, 1998

Chronic lymphocytic leukemia: where are we and where are we going? ⬇️

scientific article published on 07 July 2012

Classification updates and clinical investigations in indolent non-Hodgkin lymphoma.

scientific article

Clinical Advances in Hematology & Oncology. Letter from the editor

scientific article published in September 2014

Clinical Roundtable Monograph: current treatment options for NHL patients refractory to standard therapy: recent data in single-agent and combination therapy.

scientific article

Clinical Trials Referral Resource. Clinical trials in AIDS related malignancies

scientific article published on 01 March 1997

Clinical Trials Referral Resource. Clinical trials in bladder and urothelial cancers

scientific article published on 01 September 1997

Clinical Trials Referral Resource. Trials using tumor vaccines

scientific article published on 01 January 1997

Clinical Trials Referral Resource: Mycosis Fungoides/Sézary Syndrome

scientific article published on 01 July 1995

Clinical Trials. Referral resource Clinical trials using CI-980 (mivobulin isethionate).

scientific article published in May 1997

Clinical advances in hematology & oncology

scientific article published on 01 January 2012

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

article

Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology

scientific article published on 17 December 2007

Clinical management of T-cell malignancies: current perspectives, key issues, and emerging therapies

scientific article published on December 2007

Clinical toxicity associated with tiazofurin

scientific article

Clinical trails referral resource. Clinical trials of adenovirus-p53 gene therapy.

scientific article published in August 1998

Clinical trails referral resource. Metastatic breast cancer

scientific article published on 01 April 1998

Clinical trials Referral Resource. Clinical trials at the medicine branch of the NCI--Part I

scientific article published on 01 April 1995

Clinical trials at the medicine branch of the NCI-part 2

scientific article published on 01 June 1995

Clinical trials in hairy cell leukemia. Current status and future directions

scientific article

Clinical trials referral resource

scientific article

Clinical trials referral resource

scientific article published on 01 February 1991

Clinical trials referral resource

scientific article published on 01 June 1992

Clinical trials referral resource

scientific article published on 01 October 1990

Clinical trials referral resource

scientific article published on 01 December 1990

Clinical trials referral resource

scientific article published on 01 November 1990

Clinical trials referral resource

scientific article published on 01 March 1993

Clinical trials referral resource

scientific article published on 01 December 1995

Clinical trials referral resource

scientific article published on 01 May 1994

Clinical trials referral resource

scientific article published on 01 June 1994

Clinical trials referral resource

scientific article published on 01 August 1997

Clinical trials referral resource. AIDS-related non-Hodgkin's lymphomas

scientific article published on 01 April 1993

Clinical trials referral resource. Acute lymphocytic leukemia

scientific article published on 01 May 1993

Clinical trials referral resource. Adjuvant therapy for colon cancer

scientific article published on 01 April 1990

Clinical trials referral resource. Adjuvant therapy for rectal cancer

scientific article published on May 1, 1991

Clinical trials referral resource. Adjuvant therapy in breast cancer.

scientific article published in November 1994

Clinical trials referral resource. Adjuvant therapy of breast cancer

scientific article published on 01 June 1989

Clinical trials referral resource. Adjuvant treatment of colon cancer

scientific article published on 01 September 1989

Clinical trials referral resource. Advanced breast cancer

scientific article published on 01 July 1989

Clinical trials referral resource. Bladder cancer

scientific article published on 01 January 1992

Clinical trials referral resource. Bone marrow transplantation for breast cancer

scientific article published on 01 September 1991

Clinical trials referral resource. Breast cancer

scientific article published on July 1, 1991

Clinical trials referral resource. Breast cancer and prostate cancer

scientific article published on 01 January 1996

Clinical trials referral resource. Cancer chemoprevention and control trials

scientific article published on 01 April 1996

Clinical trials referral resource. Children with brain tumors

scientific article published on March 1, 1998

Clinical trials referral resource. Clinical trials at the surgery branch of the NCI

scientific article published on 01 May 1995

Clinical trials referral resource. Clinical trials for children with acute leukemia

scientific article published on 01 November 1996

Clinical trials referral resource. Clinical trials in adult acute myelogenous leukemia

scientific article published on 01 February 1998

Clinical trials referral resource. Clinical trials in elderly patients

scientific article published on 01 June 1997

Clinical trials referral resource. Clinical trials in gastric cancer

scientific article published on 01 December 1998

Clinical trials referral resource. Clinical trials in head and neck cancer

scientific article published on 01 October 1997

Clinical trials referral resource. Clinical trials in lung cancer

scientific article published on 01 November 1997

Clinical trials referral resource. Clinical trials in non-Hodgkin's Lymphoma

scientific article published on 01 September 1998

Clinical trials referral resource. Clinical trials in non-small-cell lung cancer

scientific article published on 01 October 1999

Clinical trials referral resource. Clinical trials in the CNS Consortia

scientific article published on 01 August 1996

Clinical trials referral resource. Clinical trials of MGI-114

scientific article published on 01 February 1999

Clinical trials referral resource. Clinical trials of combination regimens containing oxaliplatin

scientific article published on 01 August 1999

Clinical trials referral resource. Clinical trials of dolastatin-10

scientific article published on 01 January 1999

Clinical trials referral resource. Clinical trials of flavopiridol

scientific article published on July 1, 1998

Clinical trials referral resource. Clinical trials of multimodality approaches for advanced esophageal cancer

scientific article published on 01 June 1998

Clinical trials referral resource. Clinical trials of single-agent oxaliplatin

scientific article published on 01 July 1999

Clinical trials referral resource. Clinical trials of suramin

scientific article published on 01 February 1995

Clinical trials referral resource. Clinical trials using bryostatin-1

scientific article published on 01 May 1996

Clinical trials referral resource. Clinical trials using compound 506U78

scientific article published on 01 December 1996

Clinical trials referral resource. Clinical trials using edatrexate

scientific article published on 01 July 1993

Clinical trials referral resource. Clinical trials using gemcitabine

scientific article published on 01 June 1996

Clinical trials referral resource. Clinical trials using monoclonal antibodies

scientific article published on 01 October 1998

Clinical trials referral resource. Clinical trials using thalidomide

scientific article published on 01 October 1996

Clinical trials referral resource. Clinical trials with 2-chlorodeoxyadenosine

scientific article published on 01 May 1992

Clinical trials referral resource. Clinical trials with Docetaxel (Taxotere)

scientific article published on 01 September 1993

Clinical trials referral resource. Clinical trials with PSC-833

scientific article published on 01 April 1997

Clinical trials referral resource. Clinical trials with all-trans-retinoic acid

scientific article published on April 1, 1992

Clinical trials referral resource. Clinical trials with arsenic trioxide

scientific article published on 01 February 2000

Clinical trials referral resource. Clinical trials with gadolinium-texaphyrin and lutetium-texaphyrin.

scientific article published in May 1999

Clinical trials referral resource. Clinical trials with paclitaxel in metastatic breast cancer

scientific article published on 01 January 1994

Clinical trials referral resource. Clinical trials with perillyl alcohol

scientific article published on 01 December 1997

Clinical trials referral resource. Clinical trials with pyrazoloacridine

scientific article published on 01 July 1997

Clinical trials referral resource. Clinical trials with taxol

scientific article published on 01 March 1992

Clinical trials referral resource. Clinical trials with the farnesyl transferase inhibitor R115777

scientific article published on 01 November 1999

Clinical trials referral resource. Clinical trials with tomudex

scientific article published on 01 July 1996

Clinical trials referral resource. Clinical trials with topotecan

scientific article published on 01 February 1993

Clinical trials referral resource. Colon cancer

scientific article published on 01 August 1994

Clinical trials referral resource. Current clinical trials for the proteasome inhibitor PS-341

scientific article published on 01 November 2000

Clinical trials referral resource. Current clinical trials in cervical cancer

scientific article published on 01 July 2000

Clinical trials referral resource. Current clinical trials in endometrial cancer

scientific article published on 01 June 2000

Clinical trials referral resource. Current clinical trials in epithelial ovarian cancer

scientific article published on 01 May 2000

Clinical trials referral resource. Current clinical trials in myelodysplatsic syndromes

scientific article published on 01 January 2001

Clinical trials referral resource. Current clinical trials in neuroblastoma.

scientific article published in January 2002

Clinical trials referral resource. Current clinical trials in non-Hodgkin's lymphoma

scientific article published on 01 June 2002

Clinical trials referral resource. Current clinical trials in pediatric acute lymphoblastic leukemia

scientific article published on 01 December 2000

Clinical trials referral resource. Current clinical trials in prostate cancer

scientific article published on 01 March 2000

Clinical trials referral resource. Current clinical trials in small-cell lung cancer

scientific article published on 01 March 2001

Clinical trials referral resource. Current clinical trials of R115777 (Zarnestra).

scientific article published in July 2002

Clinical trials referral resource. Current clinical trials of epothilone B analog (BMS-247550).

scientific article

Clinical trials referral resource. Current clinical trials of fenretinide

scientific article published in December 2001

Clinical trials referral resource. Current clinical trials of molecularly targeted agents in children with cancer.

scientific article

Clinical trials referral resource. Current clinical trials of the anti-CD20 monoclonal antibody rituximab

scientific article published on 01 October 2000

Clinical trials referral resource. Current cooperative group phase III clinical trials in early-stage breast cancer

scientific article published on 01 February 2001

Clinical trials referral resource. Current trials in melanoma

scientific article published on 01 September 1999

Clinical trials referral resource. Extensive-stage small-cell lung cancer

scientific article published on 01 November 1993

Clinical trials referral resource. Gastric and esophageal cancers

scientific article published on 01 October 1991

Clinical trials referral resource. Head and neck cancer

scientific article published on 01 August 1992

Clinical trials referral resource. High Priority Trials

scientific article published in October 1992

Clinical trials referral resource. High priority trials--III. Breast cancer

scientific article published on 01 December 1992

Clinical trials referral resource. High-dose chemo for acute myeloid leukemia

scientific article published on 01 July 1990

Clinical trials referral resource. High-grade and low-grade gliomas

scientific article published on March 1, 1991

Clinical trials referral resource. Integrating economic analysis into cooperative group trials.

scientific article published in November 1998

Clinical trials referral resource. Melanoma

scientific article published on 01 June 1991

Clinical trials referral resource. Metastatic breast cancer

scientific article published on 01 December 1993

Clinical trials referral resource. Multicenter phase I and II trials in adults with high-grade gliomas

scientific article published in April 1999

Clinical trials referral resource. Multicenter trials of therapies for adult brain tumors.

scientific article published in March 1999

Clinical trials referral resource. Multiple myeloma

scientific article published on 01 December 1991

Clinical trials referral resource. Multiple myeloma and Waldenström's macroglobulinemia phase III trials

scientific article published on 01 July 1994

Clinical trials referral resource. Myelodysplastic syndromes

scientific article published on 01 September 1995

Clinical trials referral resource. NCI-Navy: T-cell lymphoma or chronic lymphocyte leukemia

scientific article published on 01 September 1990

Clinical trials referral resource. NCI-Navy: small cell lung cancer

scientific article published on 01 September 1990

Clinical trials referral resource. NCI-sponsored trials of PIXY321

scientific article published on 01 August 1993

Clinical trials referral resource. NCI-sponsored trials of interleukin-6 (IL-6)

scientific article published on 01 June 1993

Clinical trials referral resource. NSABP breast cancer trials

scientific article published on 01 August 1991

Clinical trials referral resource. New autologous stem-cell transplant protocols

scientific article published on 01 February 1997

Clinical trials referral resource. Non-Hodgkin's lymphoma.

scientific article published in October 1989

Clinical trials referral resource. Non-small-cell lung cancer

scientific article published on 01 July 1992

Clinical trials referral resource. Non-small-cell lung cancer

scientific article published on 01 February 1990

Clinical trials referral resource. Non-small-cell lung cancer.

scientific article

Clinical trials referral resource. Ovarian cancer

scientific article published in August 1990

Clinical trials referral resource. Ovarian cancer: phase II trials

scientific article published on 01 March 1994

Clinical trials referral resource. Pediatric studies

scientific article published on 01 January 1991

Clinical trials referral resource. Primary central nervous system tumors.

scientific article published in October 1994

Clinical trials referral resource. Prostate cancer

scientific article published on 01 November 1989

Clinical trials referral resource. Prostate cancer II

scientific article published on 01 January 1995

Clinical trials referral resource. Prostate cancer.

scientific article published in December 1994

Clinical trials referral resource. Protocols for elderly patients with acute myeloid leukemia

scientific article published on 01 November 1991

Clinical trials referral resource. Rectal cancer

scientific article published on 01 June 1990

Clinical trials referral resource. Rectal cancer

scientific article published on 01 September 1994

Clinical trials referral resource. Rhabdomyosarcoma

scientific article published on 01 September 1992

Clinical trials referral resource. ST1571.

scientific article

Clinical trials referral resource. Sarcomas

scientific article published on 01 March 1990

Clinical trials referral resource. Small-cell lung cancer

scientific article published on 01 October 1993

Clinical trials referral resource. Small-cell lung cancer.

scientific article

Clinical trials referral resource. Targeted therapy in squamous cell cancers of the head and neck.

scientific article published in May 2002

Clinical trials referral resource. Treatment of advanced colorectal cancer.

scientific article

Clinical trials referral resource. Trials of topotecan

scientific article published on 01 March 1995

Clinical trials referral resource. Tumor Vaccine Trials

scientific article published on 01 May 1998

Clinical trials referral resource. Tumor vaccine clinical trials

scientific article published on 01 October 1995

Clinical trials referral resource. Update on taxol trials

scientific article published on 01 January 1993

Clinical trials referral resource: Current clinical trials of the anti-VEGF monoclonal antibody bevacizumab

scientific article published on 01 August 2001

Clinical trials referral source. Clinical trials assessing quality of life

scientific article published on 01 January 1998

Clinical trials, referral resource. Treatment of advanced or recurrent squamous cell carcinoma of the head and neck

scientific article published on 01 April 2000

Clinical trials. Current clinical trials in pediatric sarcoma

scientific article published on 01 December 1999

Clinical trials. NCI clinical trials in colon cancer

scientific article published on 01 June 1999

Clinical trials. Referral resource. Clinical trials assessing quality of life.

scientific article

Clinical trials. Referral resource. Phase II Ovarian Cancer Trials

scientific article published on 01 April 1994

Clinical utility of body fluid analyses

scientific article

Cogan's syndrome

scientific article published on 01 December 2010

Cogan's syndrome and Bw 17 revisited.

scientific article published in July 1977

Cogan's syndrome: A systemic vasculitis ⬇️

scientific article published on 01 April 1976

Combinations or sequences of targeted agents in CLL: is the whole greater than the sum of its parts (Aristotle, 360 BC)?

scientific article published on 14 November 2018

Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukaemia

scientific article published on 20 February 2020

Complete response to brentuximab vedotin in a transplant-naïve patient with relapsed CD30-positive nodular lymphocyte-predominant Hodgkin lymphoma.

scientific article published in June 2013

Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus 131I-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016.

scientific article published on 22 January 2018

Copanlisib in the treatment of non-Hodgkin lymphoma

scientific article published on 13 July 2020

Current Status of U.S. Clinical Trials in Chronic Lymphocytic Leukemia

scientific article

Current approaches to the chemotherapy of B-cell chronic lymphocytic leukemia: a review

scientific article published on September 1989

Current approaches to therapy for indolent non-Hodgkin's lymphoma.

scientific article

Current role of FDG PET/CT in lymphoma

scientific article published on 12 February 2014

Current status and future directions of clinical trials in chronic lymphocytic leukemia

scientific article published on October 1987

Cutis verticis gyrata: unusual chloromatous disease in acute myelogenous leukemia

scientific article published on 01 January 1980

Cytologic evidence for disseminated immunoblastic lymphoma

scientific article published on 01 April 1981

Defective binding of the third component of complement (C3) to Streptococcus pneumoniae in multiple myeloma

scientific article published on 01 April 1984

Defective complement activity in chronic lymphocytic leukemia.

scientific article

Defective opsonization in multiple myeloma.

scientific article published in April 1980

Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia

scientific article published on June 1988

Descriptive analysis of genetic aberrations and cell of origin in Richter transformation

scientific article published on 11 January 2019

Detection of minimal residual disease following induction immunochemotherapy predicts progression free survival in mantle cell lymphoma: final results of CALGB 59909

scientific article

Determining the sequence of novel therapies in the treatment of relapsed Hodgkin's lymphoma

scientific article published on 05 September 2018

Developmental history: bendamustine yesterday, today, tomorrow

scientific article

Differentiating agents in the treatment of human malignancies

scientific article

Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303

scientific article published on 02 April 2019

Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy

scientific article

Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET

scientific article

EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma ⬇️

scientific article published on August 1, 1993

Efficacy of bendamustine in rituximab-refractory indolent B-cell non-Hodgkin lymphoma: review of a pivotal trial

scientific article published on January 2011

Emerging therapies and future directions in chronic lymphocytic leukaemia--chemotherapy

scientific article

Emerging treatments for indolent lymphoma.

scientific article published in May 2007

Ennui or not ennui, that is the question...

scientific article published on 01 October 1996

Etiology and management of tumor lysis syndrome in patients with chronic lymphocytic leukemia.

scientific article published on April 2009

Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era

scientific article published on 07 September 2015

Expanding our mission: Clinical Lymphoma, Myeloma & Leukemia

scientific article published on 01 August 2009

Extended Follow-up of Patients Treated With Bendamustine for Lymphoid Malignancies

scientific article published on 30 June 2017

FDG-PET for Early Response Assessment in Lymphomas: Part 1-Hodgkin Lymphoma

scientific article published on January 2017

FDG-PET for Early Response Assessment in Lymphomas: Part 2-Diffuse Large B-Cell Lymphoma, Use of Quantitative PET Evaluation

scientific article published on January 2017

FDG-PET lymphoma demonstration project invitational workshop

scientific article published on 01 March 2007

Favorable outcome of central nervous system toxoplasmosis occurring in a patient with untreated Hodgkin's disease

scientific article published on 01 February 1980

Final Results of a Randomized, Phase III Study of Rituximab With or Without Idelalisib Followed by Open-Label Idelalisib in Patients With Relapsed Chronic Lymphocytic Leukemia

scientific article published on 17 April 2019

Five Days At Memorial by Dr Sheri Fink

scientific article

Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia

scientific article (publication date: 14 December 2000)

Fludarabine phosphate--looking forward

scientific article published on 01 October 1990

Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies

scientific article published on January 1991

Frequency and impact of grade three or four toxicities of novel agents on outcomes of older patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma (alliance A151611).

scientific article published on 16 April 2018

Future strategies toward the cure of indolent B-cell malignancies: introduction.

scientific article

Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804.

scientific article

Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma

scientific article published on 26 November 2012

Genetic abnormalities in CLL: prognostic factors--or their own disease?

scientific article published on July 2011

Ghostwriting.

scientific article published on May 2008

Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group

scientific article published on November 1988

Guidelines for diagnosis, indications for treatment, response assessment and supportive management of chronic lymphocytic leukemia

scientific article published on 14 March 2018

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

scientific article

Health-related quality of life and symptoms in patients with rituximab-refractory indolent non-Hodgkin lymphoma treated in the phase III GADOLIN study with obinutuzumab plus bendamustine versus bendamustine alone

scientific article

Hematologic malignancies: new developments and future treatments

scientific article

Hematology: The case against rituximab maintenance

scientific article published in November 2009

High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - a CALGB 59804 cor

scientific article published in June 2008

High-dose melphalan and granulocyte-macrophage colony-stimulating factor for refractory multiple myeloma

scientific article published in August 1990

High-dose therapy for refractory multiple myeloma: improved prognosis with better supportive care and double transplants.

scientific article

Highlights from the 2014 Congress of the European Hematology Association

scientific article published in September 2014

Highlights from the Pan Pacific Lymphoma Conference. August 15–19, 2011, Kauai, Hawaii

scientific article published on October 1, 2011

Highlights of the 2008 International Conference on Malignant Lymphoma

scientific article published in August 2008

Histiocytic sarcoma transdifferentiated from follicular lymphoma presenting as a cutaneous tumor ⬇️

scientific article published on August 23, 2011

Histone deacetylase inhibition: a novel approach to cancer treatment.

scientific article

Hodgkin Lymphoma: Protecting the Victims of Our Success ⬇️

scientific article published on November 13, 2012

Hodgkin's Disease, Alcohol, and Vena Caval Obstruction ⬇️

scientific article published on January 2, 1978

Homoharringtonine and low-dose cytarabine in the management of late chronic-phase chronic myelogenous leukemia

scientific article published on 01 October 2000

Homoharringtonine: history, current research, and future direction

scientific article

How we manage follicular lymphoma

scientific article published on 28 February 2014

I try to be a minimalist in laboratory testing

scientific article published on 01 August 2009

Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study.

scientific article

Idelalisib and rituximab in relapsed chronic lymphocytic leukemia

scientific article

Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909.

scientific article

Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase 3 randomized trial

scientific article published on 13 February 2020

Impact of obinutuzumab alone and in combination for follicular lymphoma

scientific article published on 19 October 2017

Implementing an expressive writing study in a cancer clinic

scientific article published in February 2008

Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002.

scientific article published on 15 January 2014

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs

scientific article published on 23 July 2015

Individualizing therapy for the hematologic malignancies: the stuff of genes and dreams

scientific article published on 01 September 2005

Infectious and immunosuppressive complications of purine analog therapy ⬇️

scientific article published on September 1, 1995

Innovative strategies for the treatment of CLL.

scientific article published on October 1996

Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202).

scientific article published on 08 April 2013

Interim [(18)F]fluorodeoxyglucose positron emission tomography imaging in stage I-II non-bulky Hodgkin lymphoma: would using combined positron emission tomography and computed tomography criteria better predict response than each test alone?

scientific article published on 28 August 2012

International harmonization of trial parameters in malignant lymphoma

scientific article published on 01 July 2005

Interpretation of clinical trials in diffuse large-cell lymphoma

scientific article published on August 1988

Introduction by the Guest Editor: Staying Ahead of the Rapidly Evolving World of Chronic Lymphocytic Leukemia

scientific article published on 01 November 2019

Investigator and independent review committee exploratory assessment and verification of tumor response in a non-Hodgkin lymphoma study

scientific article

Is BEACOPP better than ABVD?

scientific article published on July 2007

Is ebola scarier than cancer?

scientific article published in November 2014

Issues for the future development of fludarabine phosphate

scientific article published on October 1, 1990

Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study

scientific article

Lance decided not to fight the allegations of doping anymore

scientific article published on 01 September 2012

Lenalidomide for the treatment of B-cell malignancies

scientific article published on 19 February 2008

Letter From the Editor: A thankful end of the year

Letter From the Editor: Doctors as writers

scientific article published in March 2016

Letter From the Editor: Fellowship interviews and more

scientific article published in October 2016

Letter From the Editor: For what it's worth

Letter From the Editor: From 2003 to today

Letter From the Editor: I love boobies

scientific article published in February 2016

Letter From the Editor: Inside my file cabinets.

scientific article

Letter From the Editor: Interviewing season

Letter From the Editor: Lies and truth.

scientific article published in March 2015

Letter From the Editor: Moonshot medicine

scientific article published on 01 April 2016

Letter From the Editor: Ode to Bob

scientific article published in November 2016

Letter From the Editor: Reflections on Lugano

scientific article published on 01 July 2015

Letter From the Editor: The end

scientific article published in December 2016

Letter From the Editor: The pedant and the scoundrel

scientific article published in May 2016

Letter From the Editor: The return of the emperor.

scientific article published in May 2015

Letter From the Editor: When Breath Becomes Air.

scientific article published in June 2016

Letter From the Editor: When will we ever learn?

scientific article published in July 2016

Letter from the Editor

scientific article published on 01 July 2014

Letter from the Editor

Letter from the Editor

Letter from the editor

scientific article published on 01 November 2004

Letter from the editor

scientific article published on 01 March 2004

Letter from the editor

scientific article published on 01 January 2005

Letter from the editor

scientific article published on 01 August 2011

Letter from the editor

scientific article published on 01 October 2011

Letter from the editor

scientific article published on 01 February 2012

Letter from the editor

scientific article published on 01 March 2012

Letter from the editor

scientific article published on 01 July 2011

Letter from the editor

scientific article published on 01 March 2010

Letter from the editor

scientific article published on 01 March 2011

Letter from the editor

scientific article published on 01 May 2012

Letter from the editor

scientific article published on 01 June 2012

Letter from the editor

scientific article published on 01 August 2012

Letter from the editor

scientific article published on 01 October 2012

Letter from the editor

scientific article published on 01 August 2014

Letter from the editor

scientific article published in May 2013

Letter from the editor

Letter from the editor

Letter from the editor

Letter from the editor

Letter from the editor

Letter from the editor

Letter from the editor

Letter from the editor

scientific article published in April 2013

Letter from the editor. Can you name the six US airports named after US presidents?

scientific article published on 01 November 2011

Letter from the editor. What it is like to be a researcher

scientific article published on February 1, 2013

Letter from the editor: the Big Bang theory

scientific article published on February 1, 2011

Letter from the editor: the campaign button

Letter: BCG therapy and urticaria

scientific article published on 01 November 1975

Life, liberty, and the pursuit of health care

scientific article published in April 2010

Long-term follow-up of CALGB (Alliance) 100001: Autologous followed by non-myeloablative allogeneic transplant for multiple myeloma

scientific article published on 20 April 2020

Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin

scientific article published on 01 November 2000

Long-term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non-Hodgkin lymphoma.

scientific article published on 17 April 2017

Long-term perspective of hematologic malignancies

scientific article published on January 1988

Low-dose ara-C in acute nonlymphocytic leukemia and myelodysplastic syndromes: a review of 20 years' experience

scientific article

Low-grade non-Hodgkin's lymphomas revisited

scientific article published on 01 September 1986

Lymphoma: looking from the present to the future

scientific article published in March 2015

MRD response in relapsed/refractory FL after obinutuzumab plus bendamustine or bendamustine alone in the GADOLIN trial

scientific article published on 28 August 2019

Making the H1N1 (Swine) flu vaccine mandatory for hospital employees

scientific article published on 01 October 2009

Male-female differences in the impact of cancer therapy.

scientific article

Management of Adverse Events From the Combination of Rituximab and Lenalidomide in the Treatment of Patients With Follicular and Low-Grade Non-Hodgkin Lymphoma

scientific article published on 20 March 2020

Management of chronic lymphocytic leukaemia

scientific article

Managing malignancy-associated hyperuricemia with rasburicase.

scientific article

Mantle cell lymphoma: clinicopathologic features and treatments

scientific article

Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma

scientific article (publication date: 7 August 2008)

Monoclonal antibodies in advanced B-cell lymphomas.

scientific article published in February 2010

Monoclonal antibody therapy for B-cell malignancies

scientific article

Monoclonal antibody therapy of chronic lymphocytic leukaemia

scientific article published on March 2010

Monoclonal antibody therapy of chronic lymphocytic leukemia

scientific article

Monoclonal antibody therapy of chronic lymphocytic leukemia

scientific article published on 27 September 2005

Monoclonal gammopathy in extranodal marginal zone lymphoma (ENMZL) correlates with advanced disease and bone marrow involvement

scientific article published on 01 October 2004

Most important accomplishments

scientific article published on 01 March 2008

Moving towards the chemo-free treatment of lymphoma: hype or reality?

scientific article published on 21 March 2022

Myelodysplastic syndromes standardized response criteria: further definition

article

National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment

scientific article

Needle tract seeding after bone marrow biopsy in non-Hodgkin lymphoma

scientific article published on 01 January 2008

Neurotoxicity of purine analogs: a review

scientific article published on October 1994

New Chemotherapeutic Agents for Non-Hodgkin’s Lymphomas ⬇️

scientific article published on October 1, 1991

New agents in follicular lymphoma ⬇️

scientific article published on May 11, 2011

New antimetabolites in the treatment of human malignancies

scientific article published on December 1, 1992

New chemotherapeutic agents for the treatment of low-grade non-Hodgkin's lymphomas

scientific article published on October 1993

New chemotherapeutic agents in non-small-cell lung cancer

scientific article published on April 1, 1993

New chemotherapeutics strategies for the treatment of indolent lymphoid malignancies.

scientific article

New drug development

scientific article published on 01 September 2009

New drug development in non-Hodgkin lymphomas

scientific article

New drugs in non-Hodgkin's lymphoma

scientific article published on January 1997

New modalities of therapy in chronic lymphocytic leukemia

scientific article published on September 1991

New prospects in the treatment of indolent lymphomas with purine analogues

scientific article published on July 1, 1998

New response criteria for lymphomas in clinical trials

scientific article published on June 2008

New staging and response criteria for non-Hodgkin lymphoma and Hodgkin lymphoma

scientific article published in March 2008

Novel targeted agents and the need to refine clinical end points in chronic lymphocytic leukemia

scientific article

Novel therapeutic agents for the treatment of myelodysplastic syndromes.

scientific article

Novel therapies for chronic lymphocytic leukemia

scientific article

Novel therapies for peripheral T-cell non-Hodgkin's lymphomas

scientific article published on July 2009

Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial

scientific article

Oblimersen for the treatment of patients with chronic lymphocytic leukemia

scientific article

Ofatumumab and bendamustine in previously treated chronic lymphocytic leukemia and small lymphocytic lymphoma

scientific article published on 6 August 2014

Ofatumumab, a novel anti-CD20 monoclonal antibody for the treatment of B-cell malignancies

scientific article

Opsonic activity of myeloma immuno‐globulins (mm‐lg) ⬇️

scientific article published on 01 December 1981

Optimal Management of Adverse Events From Copanlisib in the Treatment of Patients With Non-Hodgkin Lymphomas

scientific article published on 29 November 2018

Optimal Sequencing of Ibrutinib, Idelalisib, and Venetoclax in Chronic Lymphocytic Leukemia: Results from a Multi-Center Study of 683 Patients

scientific article

Optimal use of bendamustine in chronic lymphocytic leukemia, non-Hodgkin lymphomas, and multiple myeloma: treatment recommendations from an international consensus panel

scientific article published on February 2010

Optimal use of bendamustine in hematologic disorders: Treatment recommendations from an international consensus panel - an update

scientific article

Oral fludarabine: a viewpoint by Bruce D. Cheson

scientific article published in January 2003

Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World Experience

Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience.

scientific article published on 6 September 2016

Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial

scientific article published on 26 September 2018

Outcomes of patients with Burkitt lymphoma older than age 40 treated with intensive chemotherapeutic regimens

scientific article

Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study

scientific article published on 27 March 2018

Overcoming mechanisms of RECISTance in lymphoma

scientific article published on 01 March 2007

Overestimated value of FDG-PET based bone marrow evaluation in lymphoma: Response to Adams and Kwee

scientific article published on 8 July 2016

Overview of the revised response criteria for acute myelogenous leukemia.

scientific article

PET-CT restaging: a surrogate for follicular lymphoma?

scientific article published on 17 September 2014

PET/CT in Lymphoma: Current Overview and Future Directions

scientific article

PI3K signaling pathway in normal B cells and indolent B-cell malignancies

scientific article published on 17 November 2016

PTCL therapies: a review of treatment and outline of novel therapies

scientific article published on September 2013

Patterns of growth factor usage and febrile neutropenia among older patients with diffuse large B-cell non-Hodgkin lymphoma treated with CHOP or R-CHOP: the Intergroup experience (CALGB 9793; ECOG-SWOG 4494).

scientific article published on 14 December 2016

Pentostatin in hairy cell leukemia: treatment by the special exception mechanism

scientific article published in March 1989

Peripheral T-cell lymphomas: diagnosis and treatment options. Proceedings from a live roundtable, August 17, 2011, Kauai, Hawaii

scientific article published on November 1, 2011

Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients.

scientific article published on January 1995

Perspectives on purine analogues

scientific article

Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia

scientific article

Phase 1 dose-escalation study of IV ixazomib, an investigational proteasome inhibitor, in patients with relapsed/refractory lymphoma

scientific article

Phase 1 trial of rituximab, lenalidomide, and ibrutinib in previously untreated follicular lymphoma: Alliance A051103.

scientific article

Phase 2 Study of the Safety and Efficacy of Umbralisib in Patients with CLL Who Are Intolerant to BTK or PI3Kδ Inhibitor Therapy

scientific article published on 01 December 2020

Phase 2 multicentre study of single-agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance)

scientific article published on 05 February 2019

Phase 2 study of idelalisib and entospletinib: pneumonitis limits combination therapy in relapsed refractory CLL and NHL.

scientific article published on 11 March 2016

Phase I Study of the Anti-CD22 Antibody-Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

scientific article published on 6 September 2016

Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation in patients with refractory or relapsed acute leukemia

scientific article published on May 1999

Phase I study of obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia

scientific article

Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108.

scientific article

Phase II and dose-escalation with or without granulocyte colony-stimulating factor study of 9-aminocamptothecin in relapsed and refractory lymphomas ⬇️

scientific article published on July 1, 1998

Phase II evaluation of bisantrene in refractory multiple myeloma. A Southwest Oncology Group study

scientific article

Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma

scientific article

Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas

scientific article published on 01 February 1995

Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness

scientific article

Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness

scientific article published on 01 November 2018

Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma

scientific article

Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus (131)iodine-tositumomab for previously untreated follicular non-Hodgkin lymphoma: SWOG S0016.

scientific article

Pineal region tumors: computed tomographic-pathologic spectrum

scientific article published on 01 November 1981

Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial.

scientific article published on 5 February 2013

Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS)

scientific article published on 29 March 2019

Positron-emission tomography and assessment of cancer therapy

scientific article

Pre- and post-treatment evaluation of non-Hodgkin's lymphoma

scientific article

Predicting the future for DLBCL

scientific article published on 01 April 2020

Primary Non-Hodgkin's Lymphoma of the Extrahepatic Bile Duct

scientific article published in September 2012

Prognostic Value of Interim FDG-PET in Diffuse Large Cell Lymphoma: Results from the CALGB 50303 Clinical Trial

scientific article published on 13 March 2020

Prognostic factors for patients with diffuse large cell or immunoblastic non-Hodgkin's lymphomas: experience of the non-Hodgkin's Lymphoma Pathologic Classification Project

scientific article published on 01 January 1990

Prognostic factors with high-dose melphalan for refractory multiple myeloma.

scientific article published in December 1988

Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development

scientific article (publication date: 15 April 2005)

Prolonged follow-up after initial therapy with 2-chlorodeoxyadenosine in patients with indolent non-Hodgkin lymphoma: results of Cancer and Leukemia Group B Study 9153.

scientific article published in December 2006

Pros and cons of rituximab maintenance in follicular lymphoma

scientific article published on 16 June 2017

Purine analogs in lymphoproliferative disorders

scientific article published on January 1993

Quality-of-life assessment in cancer treatment protocols: research issues in protocol development

scientific article published on April 15, 1992

RB but not R-HCVAD is a feasible induction regimen prior to auto-HCT in frontline MCL: results of SWOG Study S1106.

scientific article published on 19 December 2016

Radioimmunotherapy of non-Hodgkin lymphomas

scientific article

Radioimmunotherapy of non-Hodgkin's lymphomas

scientific article published on October 2006

Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial

scientific article published on 20 April 2015

Randomized Trial of Lenalidomide Alone Versus Lenalidomide Plus Rituximab in Patients With Recurrent Follicular Lymphoma: CALGB 50401 (Alliance).

scientific article

Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496)

scientific article

Randomized trial of ofatumumab and bendamustine versus ofatumumab, bendamustine, and bortezomib in previously untreated patients with high-risk follicular lymphoma: CALGB 50904 (Alliance)

scientific article published on 07 June 2019

Rational Approaches to Design of Therapeutics Targeting Molecular Markers ⬇️

scientific article published on January 1, 2001

Real world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States.

scientific article

Recent advances in the treatment of B-cell chronic lymphocytic leukemia

scientific article published on September 1990

Recent advances in the treatment of leukemia, lymphoma, and myeloma. [Review of Selected Presentations From the 52nd American Society of Hematology Annual Meeting and Exposition. December 4–7, 2010. Orlando, Florida]

scientific article published on April 1, 2011

Recent developments in the treatment of CLL

scientific article published on 01 May 2008

Recombinant interferon-alpha2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691.

scientific article published in October 2009

Recommendations for Clinical Trial Development in Follicular Lymphoma

scientific article published on 31 December 2016

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification

scientific article

Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy.

scientific article published on 29 August 2016

Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia

scientific article

Reply to B. Bennani-Baiti et al, H.J.A. Adams et al, E. Laffon et al, and E.A. Hawkes et al

scientific article published on 17 February 2015

Reply to G. Keramida et al.

scientific article published on 24 August 2015

Reply to M.C. Chamberlain

scientific article published on 3 February 2014

Report of an international working group to standardize response criteria for myelodysplastic syndromes.

scientific article

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

scientific article

Report of the 6th International Workshop on PET in lymphoma

scientific article published on 7 March 2017

Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia

scientific article published on May 1990

Resolution of Lymphoma-associated Open-angle Glaucoma by Rituximab ⬇️

scientific article published on August 1, 2011

Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography

scientific article

Response criteria for NHL: importance of 'normal' lymph node size and correlations with response rates

scientific article published on April 2000

Results of a phase II study of 506U78 in cutaneous T-cell lymphoma and peripheral T-cell lymphoma: CALGB 59901

scientific article published on 01 January 2007

Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma

scientific article published on 26 March 2012

Resveratrol and cancer prevention.

scientific article published in March 2009

Rethinking clinical response and outcome assessment in a biologic age.

scientific article published on June 2015

Retinoids in cancer therapy ⬇️

scientific article published on May 1, 1992

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

scientific article published on December 2003

Revised response criteria for malignant lymphoma

scientific article published on 22 January 2007

Risky management

scientific article published in July 2006

Rituximab for follicular lymphoma: maintaining an open mind ⬇️

scientific article published on March 15, 2011

Rituximab treatment of refractory fludarabine-associated immune thrombocytopenia in chronic lymphocytic leukemia.

scientific article

Rituximab: clinical development and future directions

scientific article

Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: an 8-year follow-up study of EPOCH.

scientific article

Role of bendamustine in the treatment of chronic lymphocytic leukemia

scientific article

Role of functional imaging in the management of lymphoma

scientific article published on 11 April 2011

Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.

scientific article published on September 2014

Role of positron emission tomography in lymphoma

scientific article

Safe and effective treatment of aggressive non-hodgkin lymphoma with rituximab and bendamustine in patients with severe liver impairment

scientific article published on March 1, 2013

Safety and disease response to MEDI-551, an anti-CD19 antibody, in chronic lymphocytic leukemia patients previously treated with rituximab.

scientific article published on 7 November 2013

Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trials.

scientific article

Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias

scientific article published on 01 August 1999

Sequential doxorubicin and topotecan in relapsed/refractory aggressive non-Hodgkin's lymphoma: results of CALGB 59906

scientific article published on 01 August 2006

Sequential homoharringtonine and interferon-alpha in the treatment of early chronic phase chronic myelogenous leukemia

scientific article

Serious pulmonary toxicity in patients with Hodgkin's lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an FcγRIIIa-158 V/F polymorphism

scientific article

Serving interests in hematologic malignancies in the journal of clinical oncology

scientific article

Single agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: cancer and leukemia Group B protocol 50206.

scientific article

Small molecules, big challenges

scientific article published in April 2015

Some like it hot!

scientific article published on 01 October 2001

Speaking volumes about volumes

scientific article published on 01 May 2018

Speed bumps on the road to a chemotherapy-free world for lymphoma patients

scientific article

Splenectomy for Immune Thrombocytopenic Purpura ⬇️

scientific article published on May 1, 1981

Staging and evaluation of the patient with lymphoma

scientific article published on October 2008

Staging and response assessment in lymphomas: the new Lugano classification

scientific article

Standard and low-dose chemotherapy for the treatment of myelodysplastic syndromes ⬇️

scientific article published on 01 May 1998

State-of-the-Art Research on "Lymphomas: Role of Molecular Imaging for Staging, Prognostic Evaluation, and Treatment Response".

scientific article published on 04 September 2013

Study design in chronic lymphocytic leukemia

scientific article published on 01 January 1988

Successful Treatment of Ocular Chronic Lymphocytic Leukemia with Ibrutinib: Case Report and Review of the Literature

scientific article published on 20 April 2020

Summer happenings in Hematology 2011. Highlights in Hematological Malignancies form the 2011 American Society Clinical Oncology Annual Meeting and the 16th Congress of the European Hematology Association, and the 11th International Conference on Mal

scientific article published on August 1, 2011

Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma.

scientific article

Suramin therapy in AIDS and related disorders. Report of the US Suramin Working Group

scientific article

Surrogate Endpoints and Risk Adaptive Strategies in Previously Untreated Follicular Lymphoma

scientific article published on 05 May 2018

Syk [sic] of the same old chemotherapy?

scientific article published on 01 April 2010

Systemic treatment of advanced and recurrent endometrial carcinoma: current status and future directions

scientific article published on June 1991

Targeted Therapies in Chronic Lymphocytic Leukemia: Is 2 (or 3) Better Than 1?

scientific article published on 01 November 2019

Targeted treatment and new agents in follicular lymphoma

scientific article published on 24 June 2010

Targeting Biology in Non-Hodgkin Lymphoma

scientific article published on 07 May 2019

Thalidomide has limited single-agent activity in relapsed or refractory indolent non-Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B.

scientific article published in February 2008

The "ASC(ST)O" meeting

scientific article published on 01 June 2015

The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy

scientific article published on 24 August 2020

The International Harmonization Project for response criteria in lymphoma clinical trials

scientific article published on October 2007

The Myelodysplastic Syndromes

scientific article published on 01 January 1997

The Non-Hodgkin Lymphoma Pathologic Classification Project. Long-term follow-up of 1153 patients with non-Hodgkin lymphomas

scientific article published in December 1988

The Peoria Principle

scientific article published on 01 October 2004

The Plk1 inhibitor BI 2536 in patients with refractory or relapsed non-Hodgkin lymphoma: a phase I, open-label, single dose-escalation study

scientific article

The Role of Complement and IgG in Zymosan Opsonization ⬇️

scientific article published on 01 January 1981

The anti-CD80 primatized monoclonal antibody, galiximab, is well-tolerated but has limited activity in relapsed Hodgkin lymphoma: Cancer and Leukemia Group B 50602 (Alliance).

scientific article

The binding of opioid peptides to the Mcg light chain dimer: flexible keys and adjustable locks

scientific article published in September 1987

The cancer and leukemia group B lymphoma committee

scientific article

The case against heavy PETing

scientific article published on 9 March 2009

The creative destruction of medicine

scientific article published in January 2015

The curious case of the baffling biological

scientific article published on 01 May 2000

The current status and future impact of targeted therapies in non-Hodgkin lymphoma ⬇️

scientific article published on April 1, 2013

The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia

scientific article published on 04 November 2019

The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496

scientific article published on 29 January 2013

The gift that keeps on giving

scientific article published on 01 November 2006

The interviewing of the fellows

scientific article published in October 2014

The maturation of differentiation therapy

scientific article published on 01 August 1992

The myelodysplastic syndromes: current approaches to therapy

scientific article published on June 1990

The new and ever changing PhRMA guidelines are impeding productive relationship

scientific article published on 01 June 2009

The optimal management of follicular lymphoma: an evolving field

scientific article published on September 2013

The origin of the chemiluminescence of phagocytosing granulocytes ⬇️

scientific article published on October 1, 1976

The oxidative killing mechanisms of the neutrophil

scientific article published on January 1, 1977

The potential for eliminating chemotherapy in indolent non-Hodgkin lymphoma

scientific article published on September 2013

The prognostic significance of PFS24 in follicular lymphoma following firstline immunotherapy: A combined analysis of 3 CALGB trials

scientific article published on 21 December 2018

The progress and promise of molecular imaging probes in oncologic drug development

scientific article published in November 2005

The purine analogs--a therapeutic beauty contest

scientific article

The purine analogs--a therapeutic beauty contest ⬇️

scientific article published on 01 March 1992

The repression-sensitization scale and measures of prejudice

scientific article published on 01 April 1970

The role of FDG-PET scans in patients with lymphoma

scientific article published on 20 August 2007

The role of body mass index in survival outcome for lymphoma patients: US intergroup experience

scientific article published on March 2014

The role of idelalisib in the treatment of relapsed and refractory chronic lymphocytic leukemia

scientific article

The role of radioimmunotherapy with yttrium-90 ibritumomab tiuxetan in the treatment of non-Hodgkin lymphoma

scientific article

The sarcoid-lymphoma syndrome

scientific article published on August 2010

The systemic administration of intravenous melphalan

scientific article published on November 1988

The urinary myeloma cast. Frequency of detection and clinical correlations in 30 patients with multiple myeloma

scientific article published on 01 April 1985

Therapy for diffuse large B-cell lymphoma: getting personal ⬇️

scientific article published on April 22, 2013

Therapy for previously untreated chronic lymphocytic leukemia: a reevaluation

scientific article published on 01 July 1998

Therapy with bortezomib plus lenalidomide for relapsed/refractory mantle cell lymphoma: final results of a phase II trial (CALGB 50501)

scientific article

Time To Remember To Forget Dose-Intensification in Lymphoma ⬇️

scientific article published on September 19, 2011

Total therapy with tandem transplants for newly diagnosed multiple myeloma

scientific article published on 01 January 1999

Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis

scientific article published in February 2018

Trans-retinoic acid and related differentiation agents

scientific article published on December 1992

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients ⬇️

scientific article published on 01 September 1998

Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up report

scientific article published on February 1997

Trials and tribulations

scientific article published on 01 January 1997

Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia with Novel Targeted Agents.

scientific article published on 29 August 2017

Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical Practice

scientific article published on 19 April 2019

Tumor lysis syndrome: an uncommon complication of fludarabine therapy of chronic lymphocytic leukemia ⬇️

scientific article published on 01 July 1998

US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.

scientific article published on 11 April 2016

Ultrastructural evidence for persistent gold in the bone marrow of a patient with aplastic anemia

scientific article published on 01 January 1986

Update on epidemiology and therapeutics for non-Hodgkin's lymphoma

scientific article

Urinary cytodiagnosis of renal involvement in disseminated histiocytic lymphoma

scientific article published on 01 March 1984

Urinary cytodiagnostic abnormalities in 50 patients with non-Hodgkin's lymphomas

scientific article published on 01 November 1984

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

scientific article published on 22 January 2007

Utility of positron emission tomography-computed tomography in patients with chronic lymphocytic leukemia following B-cell receptor pathway inhibitor therapy

scientific article published on 28 March 2019

Value of open-lung biopsy in 87 immunocompromised patients with pulmonary infiltrates

scientific article published on 01 January 1985

Venetoclax for chronic lymphocytic leukaemia patients who progress after more than one B-cell receptor pathway inhibitor

scientific article published on 27 November 2018

Venetoclax for chronic lymphocytic leukaemia progressing after ibrutinib: an interim analysis of a multicentre, open-label, phase 2 trial

scientific article published on 12 December 2017

Waiting Is the Hardest Part ⬇️

scientific article published on September 24, 2012

We need the Annual Oncology Awards

scientific article published in March 2006

What Is the Role of Chemotherapy in Patients With Chronic Lymphocytic Leukemia?

scientific article published on 12 July 2017

What is anaplastic large cell lymphoma?

scientific article published on 01 December 2004

What is new in lymphoma?

scientific article published in September 2004

What is the status of novel anti-CD20 antibodies for chronic lymphocytic leukemia and are they set to leave rituximab in the shadows?

scientific article published on 14 September 2015

When I came to the National Cancer Institute

scientific article published in May 2014

Which Hodgkin's patients in the Unites States should be treated with BEACOPP?

scientific article published on 01 September 2014

Paulina is supported by:

About Paulina

Help